logo BDSP

Base documentaire

  1. Disease management contracting : Legal issues.

    Article, Communication - En anglais

    Disease Management : Separating Fact From Fantasy. Conference. Tucson, Arizona (USA), 1996/01/23.

    The legal issues surrounding disease management (DM) agreements can be complex and confusing to participants whose primary expertise is in the management or providing of health care.

    Because DM is such a rapidly evolving field, attorneys can provide invaluable guidance in avoiding legal pitfalls that can arise from the partners'sometimes-differing goals and expectations.

    Although managed-care organizations (MCOs) are generally already familiar with the legal issues in DM, the independent partners in DM agreements, often drug companies, may be less familiar with the various state and federal licensing and regulatory requirements that may apply to their DM activities.

    For this reason, it is important that, unless they are prepared to take on the responsibilities involved with licensing and regulation, independent partners of MCOs should contractually state that they are not « health care providers » and should not engage in activities that would make them subject to regulation.

    In addition, partnership contracts must be carefully defined to avoid running afoul of federal and state anti-kickback laws, which prohibit certain impermissible inducements to purchase health care products or services covered by Medicare/Medicaid.

    Mots-clés Pascal : Médicament, Chimiothérapie, Traitement, Contrat, Législation, Economie santé, Politique sanitaire, Etats Unis, Amérique du Nord, Amérique, Choix, Coût, Homme

    Mots-clés Pascal anglais : Drug, Chemotherapy, Treatment, Contract, Legislation, Health economy, Health policy, United States, North America, America, Choice, Costs, Human

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0159948

    Code Inist : 002B02A07. Création : 21/05/1997.